Cirrhosis - Nursing Case Study
Pathophysiology
• Primary mechanism: Chronic liver injury from factors like alcohol use, hepatitis, or nonalcoholic fatty liver disease leads to persistent inflammation. This triggers activation of hepatic stellate cells, resulting in excessive collagen deposition and fibrosis, which disrupts normal liver architecture and function.
• Secondary mechanism: As fibrosis progresses, nodular regeneration occurs, causing increased portal pressure (portal hypertension) and impaired blood flow through the liver. This results in complications such as ascites and varices.
• Key complication: Portal hypertension can lead to the development of esophageal varices, which are prone to rupture, causing life-threatening bleeding.
Patient Profile
Demographics:
52-year-old male, construction worker
History:
• Key past medical history: Chronic alcohol use for 20 years, Hepatitis C infection diagnosed 5 years ago
• Current medications: Lactulose, Propranolol, Vitamin K supplements
• Allergies: Penicillin
Current Presentation:
• Chief complaint: Increasing abdominal swelling and discomfort
• Key symptoms: Jaundice, fatigue, peripheral edema, confusion, decreased appetite
• Vital signs: Blood pressure 100/70 mmHg, heart rate 110 bpm, respiratory rate 22 breaths per minute, temperature 99.1°F, SpO2 94% on room air
Section 1
As the case progresses, the patient experiences a change in status marked by worsening confusion and altered mental status, suggesting the development of hepatic encephalopathy. His family reports increased forgetfulness and disorientation over the past two days. During the initial assessment, the nurse notes the patient is lethargic and has difficulty concentrating during the interview. Asterixis, a flapping tremor of the hands, is observed, indicating a neurological impact due to the accumulation of toxins such as ammonia, which the compromised liver can no longer adequately process.
Laboratory results reveal elevated ammonia levels at 145 µmol/L (normal range 11-35 µmol/L), further supporting the diagnosis of hepatic encephalopathy. The patient's liver function tests show worsening values, with a bilirubin level of 5.8 mg/dL (normal range 0.1-1.2 mg/dL) and INR elevated at 1.8 (normal range 0.9-1.1), suggesting deteriorating synthetic function of the liver. Additionally, the ascites has increased, as evidenced by a weight gain of 2 kg over the past week and dullness to percussion in the flanks upon physical examination.
In response to these changes, the healthcare team adjusts the patient's management plan. Lactulose dosage is increased to reduce ammonia levels, and dietary protein intake is carefully monitored to prevent further exacerbation of encephalopathy. Propranolol is continued to manage portal hypertension, while diuretics are considered to help with fluid overload and ascites. The team discusses the importance of alcohol cessation and considers enrolling the patient in a liver transplant evaluation program, given the progression of liver decompensation. This change in patient status highlights the need for ongoing assessment and adjustment of the treatment plan to address emerging complications and maintain stability.
Section 2
In the days following the adjustment of the patient's management plan, there is a noticeable change in his clinical status. The patient, previously lethargic and confused, now exhibits signs of mild improvement after the increased lactulose dosage. His ammonia levels have decreased slightly to 120 µmol/L, indicating a positive response to the intervention. However, despite this improvement, his mental status remains fragile, with periodic episodes of confusion and disorientation continuing to be reported by his family. The nursing team conducts regular assessments, noting that his asterixis persists but is less pronounced than during the initial assessment. This mixed response prompts the healthcare team to reassess the balance of his medication regimen and dietary intake, emphasizing the delicate nature of managing hepatic encephalopathy.
Vital signs during the latest assessment are stable, with blood pressure reading at 110/70 mmHg, heart rate at 78 beats per minute, respiratory rate at 18 breaths per minute, and temperature at 98.6°F. However, the patient reports increasing abdominal discomfort and bloating, suggestive of worsening ascites. The nurse observes notable abdominal distension and fluid wave upon examination, prompting a follow-up ultrasound to evaluate the extent of the ascitic fluid accumulation. Given these findings, the team considers initiating a paracentesis to relieve discomfort and prevent further complications such as spontaneous bacterial peritonitis.
The healthcare team discusses the potential for new complications, such as variceal bleeding, due to the patient's portal hypertension and impaired coagulation as evidenced by the elevated INR. As part of the comprehensive care plan, they initiate prophylactic measures, including the continuation of propranolol and close monitoring for signs of gastrointestinal bleeding. The patient is also referred to a nutritionist to optimize his protein intake while minimizing the risk of encephalopathy exacerbation. This phase of the patient's journey emphasizes the importance of vigilant monitoring and proactive management to mitigate the risks associated with the progression of cirrhosis and its complications.
Section 3
New Diagnostic Results
Following the decision to conduct a paracentesis, the procedure reveals the presence of approximately 3 liters of straw-colored ascitic fluid, which is sent for laboratory analysis to rule out spontaneous bacterial peritonitis (SBP). Preliminary results indicate a white blood cell count of 300 cells/mm³ with a polymorphonuclear leukocyte (PMN) count of 250 cells/mm³, suggesting an elevated risk for SBP. The healthcare team promptly initiates empirical antibiotic therapy with intravenous cefotaxime to address the potential infection, emphasizing the critical nature of early intervention in preventing further deterioration.
In addition to the analysis of ascitic fluid, the patient's latest laboratory workup indicates a slight worsening in liver function, with an elevated bilirubin level of 3.8 mg/dL and a further increase in INR to 1.8, underscoring the ongoing decline in hepatic synthetic capacity. Renal function tests reveal a creatinine level of 1.5 mg/dL, raising concerns about hepatorenal syndrome, a potential complication of advanced cirrhosis. The multidisciplinary team carefully evaluates the patient's fluid status, adjusting diuretics and considering the judicious use of albumin to support renal perfusion.
These new diagnostic insights prompt an adjustment in the patient's management plan, with a heightened focus on infection control and renal function preservation. The healthcare team remains vigilant, closely monitoring the patient's vital signs, mental status, and laboratory values to detect any further complications promptly. This phase of the patient's journey highlights the importance of dynamic clinical reasoning and timely interventions to navigate the complexities of cirrhosis and its multifaceted complications.
Section 4
New Complications
As the healthcare team continues to manage the patient's cirrhosis and associated complications, the development of new symptoms signals the emergence of additional concerns. The patient begins to exhibit subtle changes in mental status, including increased confusion and difficulty with orientation, raising the suspicion of hepatic encephalopathy. This clinical change prompts the team to evaluate ammonia levels, which are found to be elevated at 85 µmol/L, further supporting the diagnosis. In response, lactulose therapy is initiated to reduce ammonia absorption in the gut, alongside dietary modifications aimed at optimizing protein intake without exacerbating the condition.
Concurrently, the patient's respiratory status shows signs of compromise, with new-onset mild dyspnea and a decrease in oxygen saturation levels to 92% on room air. A chest X-ray reveals mild pleural effusion, likely secondary to the patient's ascites and compromised albumin levels. This finding necessitates a reevaluation of the patient's fluid management strategy, including the consideration of thoracentesis if respiratory distress worsens. Additionally, the risk of hepatopulmonary syndrome is discussed among the team, given the interplay between liver dysfunction and pulmonary symptoms.
The patient's evolving condition requires the healthcare team to exercise dynamic clinical reasoning, adapting treatment strategies in light of these new complications. By closely monitoring the patient's response to interventions and maintaining an interdisciplinary approach, the team aims to stabilize the patient's status and prevent further deterioration. This phase of care emphasizes the importance of vigilance and proactive management in the face of cirrhosis's complex and interrelated complications, setting the stage for continued monitoring and potential adjustments in the patient's therapeutic regimen.
Section 5
As the patient's care progresses, attention turns to the response to interventions initiated for hepatic encephalopathy and respiratory compromise. Over the following days, there is a notable improvement in the patient's mental status, suggesting a positive response to lactulose therapy. The patient exhibits increased alertness and orientation, and family members report fewer episodes of confusion. Ammonia levels have decreased to 65 µmol/L, indicating effective reduction of gut-derived ammonia production. The dietary modifications, emphasizing balanced protein intake, are also believed to contribute to the stabilization of the patient's cognitive function.
Despite improvements in mental status, the respiratory symptoms warrant close monitoring. The patient's oxygen saturation continues to hover around 92% on room air, with occasional dips to 90%. A follow-up chest X-ray shows no significant change in the pleural effusion, suggesting that it remains stable. However, the patient reports intermittent episodes of shortness of breath, particularly when supine. These findings prompt the team to consider a low-dose diuretic therapy to manage fluid overload while mitigating the risk of aggravating the patient's renal function, which remains a delicate balance due to the existing cirrhosis and potential hepatorenal syndrome.
The interdisciplinary team continues to engage in dynamic clinical reasoning, weighing the potential benefits and risks of each intervention. They also discuss the possibility of hepatopulmonary syndrome, given the persistent respiratory symptoms. An echocardiogram is ordered to assess for intrapulmonary vascular dilations, a hallmark of this syndrome. The team remains vigilant, recognizing the need for a coordinated approach to manage the multifaceted challenges presented by the patient's cirrhosis and its complications. This phase underscores the importance of ongoing assessment and the willingness to adapt the therapeutic plan as the clinical picture evolves.